Corcept Therapeutics (CORT) Financials: Revenue & Earnings

CORT price $87.30 -0.29 -0.33%

Ticker
CORT
Price
$87.30
Change
-0.29 -0.33%
Market cap ?
$9.44B
P/E ?
167.55
Forward P/E ?
42.87
Dividend yield ?
0.00%
Beta ?
0.45
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Stocklytics score
47
Value
40
Quality
41
Growth
59

Stocklytics score rationale: value 40, quality 41, growth 59.

Financials

2016201720182019202020212022202320242025
81321000159201000251247000306486000353874000365978000401858000482375000675040000761407000

Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for…

Fair value

CORT fair value $177.11. Price $87.30. Price is 51% below fair value.

Below fair value, around its usual discount.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 154.86M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 108.10M. Net debt -114.39M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare CORT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—0.79—323.90M
2026-07-290.360.02256.15M221.15M
2026-04-30-0.30-0.11164.90M185.27M
2026-02-240.200.33202.12M254.94M
2025-11-040.160.18207.64M255.35M
2025-07-310.290.23194.43M244.58M
2025-05-050.170.17157.21M216.68M
2025-02-260.260.37181.89M200.12M
2024-10-300.410.28182.55M198.02M
2024-07-290.320.23163.80M162.08M
2024-05-010.250.22146.81M141.20M
2024-02-150.280.26135.41M129.30M
2023-11-010.280.22123.60M127.82M
2023-08-020.250.15117.72M109.69M
2023-05-030.140.19105.65M104.87M
2023-02-280.140.23103.06M105.08M
2022-11-030.300.23101.73M107.57M
2022-08-030.240.24103.39M101.00M
2022-05-050.200.2493.69M98.88M
2022-02-150.260.2298.82M100.57M
2021-11-030.240.2096.13M97.65M
2021-07-290.210.1691.59M91.59M
2021-05-060.180.2179.44M88.96M
2021-02-230.200.1785.73M81.22M
2020-11-030.170.2186.33M106.64M
2020-08-040.230.2288.56M84.71M
2020-05-040.250.2293.25M82.06M
2020-02-200.240.2587.89M91.56M
2019-11-070.220.2081.50M74.10M
2019-08-010.250.1872.26M76.51M
2019-05-090.150.1964.83M82.12M
2019-02-250.180.1566.83M55.69M
2018-11-010.220.2264.44M78.25M
2018-08-090.200.2462.31M106.82M
2018-05-080.190.1657.66M65.90M
2018-02-220.170.1953.28M56.41M
2017-11-020.110.1442.76M54.43M
2017-08-010.100.0735.56M24.89M
2017-05-010.040.0327.60M20.70M
2017-03-060.040.0423.81M23.81M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-15WILSON JAMES NSell6.65K$114.48761.72K
2026-10-15WILSON JAMES NSell3.05K$115.39351.48K
2026-10-15WILSON JAMES NSell300$116.3034.89K
2026-10-02Vieira Roberto WandenkolkSell8.33K$21.63180.24K
2026-10-02Vieira Roberto WandenkolkBuy8.33K$21.63180.24K
2026-10-02Vieira Roberto WandenkolkSell1.10K$114.52125.97K
2026-10-02Vieira Roberto WandenkolkSell2.09K$115.73241.41K
2026-10-02Vieira Roberto WandenkolkSell5.15K$116.58600.06K
2026-10-02Lyon Joseph DouglasSell5.83K$19.26112.34K
2026-10-02Lyon Joseph DouglasBuy5.83K$19.26112.34K
2026-10-02Lyon Joseph DouglasSell4.45K$115.70514.39K
2026-10-02Lyon Joseph DouglasBuy3.36K$13.5645.52K
2026-10-02Lyon Joseph DouglasSell4.74K$116.54552.87K
2026-10-02Lyon Joseph DouglasSell3.36K$13.5645.52K
2026-10-02Maduck SeanSell24.59K$8.27203.33K
2026-10-02Maduck SeanBuy24.59K$8.27203.33K
2026-10-02Maduck SeanSell15.84K$116.121.84M
2026-10-02Maduck SeanSell8.74K$116.551.02M
2026-10-01Lyon Joseph DouglasBuy810$13.5610.98K
2026-10-01Lyon Joseph DouglasSell810$115.4093.47K
2026-10-01Lyon Joseph DouglasSell810$13.5610.98K
2026-10-01Maduck SeanSell413$8.273.42K
2026-10-01Maduck SeanBuy413$8.273.42K
2026-10-01Maduck SeanSell413$115.5447.72K
2026-10-01Gunn Justin FrederickBuy100.00K$114.0311.40M
2026-10-01Gunn Justin FrederickOther0——
2026-10-01Gunn Justin FrederickOther25.00K$37.94948.50K
2026-10-01Gunn Justin FrederickOther25.00K$60.581.51M
2026-10-01Gunn Justin FrederickOther8.96K$35.70319.84K
2026-09-24Robb Gary CharlesBuy5.00K——
2026-09-24Robb Gary CharlesSell17.10K——
2026-09-17Robb Gary CharlesSell17.49K$8.27144.67K
2026-09-17Robb Gary CharlesBuy17.49K$8.27144.67K
2026-09-16Vieira Roberto WandenkolkSell296$100.8229.84K
2026-09-15WILSON JAMES NSell6.80K$110.27749.83K
2026-09-15WILSON JAMES NSell400$110.8444.33K
2026-09-15WILSON JAMES NSell2.80K$111.70312.77K
2026-09-14Lyon Joseph DouglasBuy7.40K$13.56100.40K
2026-09-14Lyon Joseph DouglasBuy2.60K$11.3529.46K
2026-09-14Lyon Joseph DouglasSell7.81K$113.32885.26K
2026-09-14Lyon Joseph DouglasSell2.19K$114.12249.69K
2026-09-14Lyon Joseph DouglasSell7.40K$13.56100.40K
2026-09-14Lyon Joseph DouglasSell2.60K$11.3529.46K
2026-09-02Maduck SeanSell117$113.3813.27K
2026-09-02Mokari AtabakSell102$113.3811.56K
2026-09-02Robb Gary CharlesSell91$113.3810.32K
2026-09-02Vieira Roberto WandenkolkSell58.33K$21.631.26M
2026-09-02Vieira Roberto WandenkolkBuy58.33K$21.631.26M
2026-09-02Vieira Roberto WandenkolkSell23.60K$109.352.58M
2026-09-02Vieira Roberto WandenkolkSell23.77K$110.702.63M
2026-09-02Vieira Roberto WandenkolkSell1.54K$111.37171.18K
2026-09-02Vieira Roberto WandenkolkSell974$112.40109.47K
2026-09-02Vieira Roberto WandenkolkSell1.61K$113.72182.63K
2026-09-02Vieira Roberto WandenkolkSell5.62K$114.58644.04K
2026-09-02Vieira Roberto WandenkolkSell102$113.3811.56K
2026-09-02Vieira Roberto WandenkolkSell1.23K$115.44141.41K
2026-09-02Lyon Joseph DouglasSell72$113.388.16K
2026-09-01Guyer WilliamBuy164$113.3818.59K
2026-09-01Guyer WilliamBuy164$113.3818.59K
2026-09-01Maduck SeanSell25.00K$8.27206.75K
2026-09-01Maduck SeanBuy25.00K$8.27206.75K
2026-09-01Maduck SeanSell11.73K$113.941.34M
2026-09-01Maduck SeanSell10.99K$114.711.26M
2026-09-01Maduck SeanBuy150$113.3817.01K
2026-09-01Maduck SeanBuy150$113.3817.01K
2026-09-01Maduck SeanSell2.28K$115.61263.71K
2026-09-01Mokari AtabakBuy138$113.3815.65K
2026-09-01Mokari AtabakBuy138$113.3815.65K
2026-09-01Robb Gary CharlesBuy164$113.3818.59K
2026-09-01Robb Gary CharlesBuy164$113.3818.59K
2026-09-01Vieira Roberto WandenkolkBuy138$113.3815.65K
2026-09-01Vieira Roberto WandenkolkBuy138$113.3815.65K
2026-09-01Lyon Joseph DouglasBuy130$113.3814.74K
2026-09-01Lyon Joseph DouglasBuy130$113.3814.74K
2026-09-01Vieira Roberto WandenkolkOther0——
2026-09-01Vieira Roberto WandenkolkOther140.00K$60.588.48M
2026-09-01Vieira Roberto WandenkolkOther200.00K$21.634.33M
2026-09-01Vieira Roberto WandenkolkOther140.00K$35.705.00M
2026-08-26Park KimberlyBuy30.00K$13.49404.70K
2026-08-26Park KimberlySell30.00K$13.49404.70K
2026-08-26Park KimberlySell3.31K$122.09404.73K
2026-08-26Park KimberlySell26.68K$122.553.27M
2026-08-25Maduck SeanSell30.95K$11.35351.34K
2026-08-25Maduck SeanBuy30.95K$11.35351.34K
2026-08-25Maduck SeanSell25.09K$125.473.15M
2026-08-25Maduck SeanSell5.87K$126.06739.97K
2026-08-18MAHONEY DAVID LSell4.98K$117.47585.48K
2026-08-18MAHONEY DAVID LSell91.17K$118.2410.78M
2026-08-18MAHONEY DAVID LSell7.05K$118.88838.71K
2026-08-18MAHONEY DAVID LSell400$119.6447.86K
2026-08-17Robb Gary CharlesSell10.00K$116.261.16M
2026-08-17Robb Gary CharlesSell125——
2026-08-14Maduck SeanSell3.66K$8.2730.30K
2026-08-14Maduck SeanBuy3.66K$8.2730.30K
2026-08-14Maduck SeanSell3.66K$114.49419.49K
2026-08-14WILSON JAMES NSell3.05K$110.49337.34K
2026-08-14WILSON JAMES NSell4.67K$111.44520.21K
2026-08-14WILSON JAMES NSell2.28K$112.64256.71K
2026-08-12Robb Gary CharlesBuy3.00K——
2026-08-12Robb Gary CharlesSell11.53K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 451, holders +81 vs prior quarter. Ownership 79.26%.

HolderSharesChangeChange %Value
BLACKROCK, INC.12.43M280.75K+2.31%1.08B
INGALLS & SNYDER LLC7.93M325.79K+4.28%689.90M
RENAISSANCE TECHNOLOGIES LLC5.26M-421.15K-7.41%457.50M
VANGUARD PORTFOLIO MANAGEMENT LLC5.04M224.07K+4.65%438.63M
VANGUARD CAPITAL MANAGEMENT LLC4.17M95.29K+2.34%362.80M
PARALLEL ADVISORS, LLC3.96M-15.23K-0.38%344.51M
FMR LLC3.34M147.43K+4.62%290.21M
STATE STREET CORP3.28M78.44K+2.45%285.15M
AQR CAPITAL MANAGEMENT LLC2.58M2.18M+535.78%224.55M
GEODE CAPITAL MANAGEMENT, LLC2.53M-181.32K-6.68%220.21M
FIRST TRUST ADVISORS LP1.83M-343.83K-15.82%159.08M
TANG CAPITAL MANAGEMENT LLC1.50M00.00%130.43M
UBS GROUP AG1.38M13.99K+1.03%119.79M
DIMENSIONAL FUND ADVISORS LP1.32M-234.31K-15.09%114.68M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.16M37.62K+3.36%100.65M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.16M1.16MNew100.65M
MORGAN STANLEY1.14M118.71K+11.65%98.91M
D. E. SHAW & CO., INC.883.00K-298.35K-25.25%76.78M
CERITY PARTNERS LLC797.12K65.43K+8.94%69.31M
MPM BIOIMPACT LLC771.03K-214.67K-21.78%67.04M
NORTHERN TRUST CORP753.80K110.64K+17.20%65.54M
EMERALD ADVISERS, LLC748.33K542.77K+264.05%65.07M
FULLER & THALER ASSET MANAGEMENT, INC.710.11K710.11KNew61.74M
JACOBS LEVY EQUITY MANAGEMENT, INC695.53K695.53KNew60.48M
VANGUARD FIDUCIARY TRUST CO614.08K23.77K+4.03%53.39M

Earnings and financials

Corcept Therapeutics Incorporated (CORT) trades at $87.30, with a market cap of $9.44B and a trailing P/E of 167.55. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
81321000159201000251247000306486000353874000365978000401858000482375000675040000761407000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Corcept Therapeutics (CORT) Financials: Revenue & Earnings

CORT$87.30-0.29 -0.33%

$9.44B

Market Cap

167.55

P/E

42.87

Forward P/E

47

Score

Price History